Last updated: 29 December 2023 at 4:20pm EST

Jeff Lynn Myers Net Worth




The estimated Net Worth of Jeff Lynn Myers is at least $25.6 mil dollars as of 27 December 2023. Jeff Myers owns over 3,423 units of Beyond Air stock worth over $18,021 and over the last 2 years Jeff sold XAIR stock worth over $7,565.

Jeff Myers XAIR stock SEC Form 4 insiders trading

Jeff has made over 1 trades of the Beyond Air stock since 2023, according to the Form 4 filled with the SEC. Most recently Jeff sold 3,423 units of XAIR stock worth $7,565 on 27 December 2023.

The largest trade Jeff's ever made was selling 3,423 units of Beyond Air stock on 27 December 2023 worth over $7,565. On average, Jeff trades about 1,712 units every 0 days since 2023. As of 27 December 2023 Jeff still owns at least 46,577 units of Beyond Air stock.

You can see the complete history of Jeff Myers stock trades at the bottom of the page.



What's Jeff Myers's mailing address?

Jeff's mailing address filed with the SEC is C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530.

Insiders trading at Beyond Air

Over the last 5 years, insiders at Beyond Air have traded over $4,582,444 worth of Beyond Air stock and bought 3,519,117 units worth $12,396,434 . The most active insiders traders include Robert Carey, Steven A. Lisi y Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of $15,492. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth $18,500.



What does Beyond Air do?

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.



Complete history of Jeff Myers stock trades at Beyond Air

Persona
Trans.
Transacción
Precio total
Jeff Lynn Myers
Chief Medical Officer
Venta $7,565
27 Dec 2023


Beyond Air executives and stock owners

Beyond Air executives and other stock owners filed with the SEC include: